Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Genomics Immunology and Healthcare ETF
Similar ETFs
Trading data
IDNA performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 11, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +2.96% | +12.62% | +14.00% | +39.25% | +33.46% | -34.44% |
| Flows | +$5M | +$5M | +$5M | +$293K | -$22M | -$964K |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +22.83% | +25.56% | +24.01% | +28.14% |
Max drawdown | -6.17% | -18.64% | -30.61% | -68.19% |
Max drawdown duration | 29d | 127d | 279d | 1634d |
Time to recover | 16d | 106d | 123d | N/A |
Replication quality
Data as of February 27, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
Exposure
Data as of January 31, 2026Countries
Sectors
Diversification
Total weight of top 15 holdings out of 51
Top 15 Holdings
Characteristics
The iShares Genomics Immunology and Healthcare ETF is built to track the NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly).
This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Provider | iShares |
| N° of holdings | 51 |
| Replication method | Direct (Physical) |
| Asset class | Equities |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | June 11, 2019 |
| ESG | No |
What type of ETF is IDNA?
IDNA is a Passive ETF that provides exposure to Equity assets. It is managed by iShares.
What index does IDNA track?
IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD, aiming to replicate its performance through full replication.
What does IDNA invest in?
This ETF provides exposure to Global Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of IDNA?
The total expense ratio (TER) of IDNA is 0.47%, representing the annual fee charged by the fund manager.
When was IDNA launched?
IDNA was launched on June 11, 2019, marking its entry into the ETF market.
Who is the issuer of IDNA?
IDNA is issued by iShares.
What is the AUM of IDNA?
As of March 11, 2026, IDNA manages $153.72 M, reflecting the total assets held in the fund.
How has IDNA performed recently?
As of March 11, 2026, IDNA delivered a return of 2.96% over the past month (1M performance), 12.62% over the past three months (3M), and 14% year-to-date (YTD).
What are the recent fund flows for IDNA?
As of March 11, 2026, IDNA has seen net flows of +$5M in the past month (1M flow) and +$5M year-to-date (YTD).
Does IDNA pay dividends?
As of March 11, 2026, IDNA has a trailing 12-month distribution yield of 1.03%.
How many holdings are in IDNA
As of January 31, 2026, IDNA holds 51 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is IDNA?
As of January 31, 2026, IDNA holds 51 securities, with 62.44% of its assets concentrated in its top 15 holdings.
What are the top holdings of IDNA?
As of January 31, 2026, IDNA holds a portfolio of 51 underlyings, with its largest positions including MODERNA INC, BAYER AG and REVOLUTION MEDICINES INC. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does IDNA invest in?
As of January 31, 2026, IDNA has its largest geographic exposures in USA and France.
What sectors or themes does IDNA focus on?
As of January 31, 2026, IDNA is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.